awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46738588-0906EF15-4D19-4326-8935-145AEF2C13F3
Q46738588-0906EF15-4D19-4326-8935-145AEF2C13F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46738588-0906EF15-4D19-4326-8935-145AEF2C13F3
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
P2860
Q46738588-0906EF15-4D19-4326-8935-145AEF2C13F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46738588-0906EF15-4D19-4326-8935-145AEF2C13F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cd6a91ea349cb9e7ca8bbe4b9dd319f65e5c37a4
P2860
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).